Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring: A population-based case-control study

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 82, Issue 8, 2008, Pages 563-570

  Ács, Nándor ^a   Bánhidy, Ferenc ^a   Puhó, Erzsébet H ^b   Czeizel, Andrew E ^b,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^c NONE   (Hungary)

Author keywords

Acute pelvic inflammatory disease; Cardiovascular malformations (atrial septal defects); Congenital abnormalities; High fever; Pregnancy

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CASE CONTROL STUDY; CONGENITAL DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM SEPTUM DEFECT; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIC INFLAMMATORY DISEASE; POPULATION RESEARCH; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ABNORMALITIES, DRUG-INDUCED; ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PELVIC INFLAMMATORY DISEASE; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 50249134749     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20480     Document Type: Article

References (39)

1. Ács N, Bánhidy F, Puho HE, et al. 2005. Maternal influenza during pregnancy and risk of congenital abnormalities in the offspring. Birth Defects Res A Clin Mol Teratol 73:989-996.
2. Bánhidy F, Ács N, Puhó HE, et al. 2006a. A population-based case-control teratologic study of oral dipyrone treatment during pregnancy. Drug Safety 46:39-42.
3. Bánhidy F, Ács N, Puho HE, et al. 2006b. Maternal urinary tract infection and related drug treatments and risk of congenital abnormalities in the offspring. Br J Obstet Gynaecol 113:1465-1471.
4. Botto LD, Lynberg MC, Erickson JD. 2001. Congenital heart defect, maternal febrile diseases and multivitamin use: a population-based study. Epidemiology 12:485-490.
5. Chin BM, Lamon RF. 1997. The microbiology of preterm labour and delivery. Contemp Rev Obstet Gynecol 9:285-296.
6. Czeizel AE. 1996. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179-183.
7. Czeizel AE. 1997. First 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55:299-305.
8. Czeizel AE, Ács N, Bánhidy F, et al. 2006. Possible association between maternal diseases and congenital abnormalities. In: Engels JV, editor. Birth Defects New Research. New York: NOVA Scientific Publ. pp. 55-70.
9. Czeizel AE, Ács N, Bánhidy F, et al. 2007. Primary prevention of congenital abnormalities due to high fever related maternal diseases by antifever therapy and folic acid supplementation. Curr Women Health Rev 3:1-17.
10. Czeizel AE, Dobo M, Vargha P. 2004a. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 70:853-861.
11. Czeizel AE, Intocombining double acute accentdy Zs, Modell B. 1993. What proportion of congenital abnormalities can be prevented? Brit Med J 306:499-503.
12. Czeizel AE, Kodaj I, Lenz WC. 1994. Smoking during pregnancy and congenital limb deficiency. Brit Med J 308:1473-1476.
13. Czeizel AE, Petik D, Puho AE. 2004b. Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information. Cent Eur J Publ Health 12:179-183.
14. Czeizel AE, Petik D, Vargha P. 2003. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 12:409-416.
15. Czeizel AE, Puho E, Sorensen HT, et al. 2004c. Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy. Cong Anom (Kyoto) 544:79-86.
16. Czeizel AE, Rockenbauer M. 2000. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 88:27-33.
17. Czeizel AE, Rockenbauer M, Siffel Cs, et al. 2001a. Description and mission evaluation of the Hungarian Case - Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63:176-185.
18. Czeizel AE, Rockenbauer M, Sorensen HT, et al. 2001b. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 185:140-147.
19. Czeizel AE, Rockenbauer M, Sorensen HT, et al. 2001c. The teratogenic risk of trimethoprim-sulfonamides: A population-based case-control study. Reprod Toxicol 15:637-646.
20. Czeizel AE, Telegdi L, Tusnády G. 1988. Multiple Congenital Abnormalities. Budapest: Akadémiai Kiadó.
21. Czeizel AE, Tusnády G. 1984. Aetiological Studies of Isolated Common Congenital Abnormalities in Hungary. Budapest: Akadémiai Kiadó.
22. Divers MJ, Lilford RJ. 1993. Infection and preterm labour: a meta-analysis. Contemp Rev Obstet Gynaecol 5:71-84.
23. Donders GGG. 2007. Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynecol 21:355-373.
24. Ferencz C, Loffredo C, Correa-Villasenor A. 1997. Genetic and Environmental Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Futura Publishing Co., Inc.
25. Gjonaess H. 1982. Pelvic inflammatory diseases: Etiologic studies with emphasis on chlamidial infection. Obstet Gynecol 59:550-554.
26. Goldenberg RL, Culhane JF, Iams JD, et al. 2008. Epidemiology and causes of preterm birth. Lancet 371:75-84.
27. Hernandez-Diaz S, Werler MM, Walker AM, et al. 2000. Folic acid antagonists during: pregnancy and the risk of birth defects. N Engl J Med 343:1608-1914.
28. ICD. 1993. International Classification of Diseases. 10th revision. Geneva: WHO.
29. Kallen BAJ, Olausson PO. 2003. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:255-261.
30. Miettinen OS, Reiner ML, Nadas AS. 1970. Seasonal incidence of coarctation of the aorta. Brit Heart J 32:103-107.
31. Murphy V, Kennea NL. 2007. Antenatal infection/inflammation and fetal tissue injury. Best Pract Res Clin Obstet Gynaecol 21:479-489.
32. Shepard TH, Lemire RJ. 2004. Catalog of Teratogenic Agents, 11th ed. Baltimore, MD: Johns Hopkins University Press.
33. Stacey CM, Munday PM, Taylor-Robinson D, et al. 1992. A longitudinal study of pelvic inflammatory disease. Brit J Obstet Gynaecol 99:994-999.
34. Tikkanen J, Heinonen OP. 1991. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring. Eur J Epidemiol 7:628-659.
35. Tikkanen J, Heinonen OP. 1994. Risk factors for hypoplastic left heart syndrome. Teratology 50:112-117.
36. Torfs CP, Velie EM, Oechsli FW, et al. 1994. A population-based study of gastroschisis: Demographic, pregnancy and lifestyle risk factors. Teratology 50:44-53.
37. Werler MM, Mitchell AA, Shapiro S. 1992. Demographic reproductive, medical and environmental factors in relation to gastroschisis. Teratology 45:353-360.
38. Westron L. 1980. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 138:880-886.
39. Yarberry-Allen P, Ledger WJ, Milstein SJ. 1986. Infections of the female genital tract. In: Roberts RB, editor. Infectious Diseases: Pathogenesis, Diagnosis and Therapy. Chicago, IL: Year Book Medical Publ. pp. 87-115